What’s New in Antiretroviral Safety and Tolerability: Implications for Treatment

In this comprehensive online program led by expert faculty, review clinical strategies for applying the latest safety and tolerability data to minimize adverse events when selecting first-line ART and switching regimens in patients with HIV infection.
Kassem Bourgi, MD
Todd T. Brown, MD, PhD
Kristine Erlandson, MD
Rajesh T. Gandhi, MD
Jordan E. Lake, MD, MSc
Brian Wood, MD

Video Module

In this interactive video module, expert faculty discuss safety and tolerability considerations for ART regimen selection and strategies to individualize regimen selection to reduce AEs associated with ART in persons with HIV

Kristine Erlandson, MD Rajesh T. Gandhi, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: April 24, 2020 Expired: April 23, 2021

Downloadable Slideset

Review key data from AIDS 2020 and other sources informing individualized ART management to improve tolerability and minimize adverse events; topics include weight gain, cardiometabolic outcomes, and considerations for women of childbearing potential and during pregnancy.

Kassem Bourgi, MD Released: August 11, 2020

Review data and guideline recommendations informing ART management for specific patient populations to improve tolerability and minimize adverse events and potential drug-drug interactions

Kristine Erlandson, MD Rajesh T. Gandhi, MD Released: April 24, 2020


During the past 2 years, guidelines have shifted their recommendations on use of DTG around the time of conception and during pregnancy. As data and guidance evolve, which ART regimens should we recommend to PWH in these settings?

Brian Wood, MD Released: April 20, 2020

Certain INSTIs and TAF are associated with excessive weight gain in PWH. Here’s my take on what we know, what we don’t, and the need for clinical trials to assess mechanism and management strategies.

Jordan E. Lake, MD, MSc Released: April 27, 2020

Here’s my take on what clinicians who treat HIV need to know about bone loss risk and bone health screening in our patients.

Todd T. Brown, MD, PhD Released: September 8, 2020

Clinical Focus

In this case-based, focused activity, review the latest data from 2020 scientific meetings on weight gain, cardiometabolic endpoints, and pregnancy outcomes with current ART regimens.

Kassem Bourgi, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: August 11, 2020 Expired: August 10, 2021
Provided by USF Health

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.